Background: This study aimed to evaluate the atrial substrate in the left atrium (LA)
reduction in the rate of recurrent AF has been found when either linear ablation or ablation of CFAEs was performed in addition to PVI. 4 Meanwhile, atrial sites that represent local electrograms with high-dominant frequencies (DFs≧8 Hz) may be associated with AF maintenance. 5 Spectral analysis and frequency mapping identify localized sites of high-frequency activity during AF in humans in paroxysmal and permanent AF. Ablation at these sites results in prolongation of the AFCL and termination of paroxysmal AF (who may have relatively less LVAs), indicating their role in the maintenance of AF. 6 Therefore, high-DF sites as surrogates for localized sources maintaining AF were potential AF ablation targets. A recent study reported that a high-DF site ablation following PVI was effective in paroxysmal AF patients and nonparoxysmal AF patients with continuous AF for a duration of a few years. 5 However, the significance of DF-guided ablation is controversial. 7 Meanwhile, localized electrical sources (rotor and focal impulse) have been reported to be prevalent sustaining mechanisms of human AF using a specific computational mapping device. 8 The patients who underwent a FIRM (focal impulse and rotor modulation)-guided ablation maintained a higher freedom from AF.
Low-voltage areas (LVAs) as detected by LA voltage mapping
have been shown to be a predictor of atrial tachycardia and AF recurrence after AF ablation. 9, 10 LVAs indicate atrial structural remodeling involving atrial fibrosis and scar tissue. Although various additional LVA-guided substrate modifications after PVI have been reported in nonparoxysmal AF patients with LVAs, the outcome and approach vary widely according to the size and distribution of the LVAs. [11] [12] [13] A tailored LVA-guided ablation may need a personally adapted large or complicated lesion design in some patients. However, it is difficult to modify the diffuse fibrotic atrial areas or massive fibrosis. Whether all LVA sizes should be potential targets for modification or not remains unclear.
Further, high-DF sites can be recorded not only in LVAs but also healthy atrial myocardium. 5 The points in each region were similar in number and nearly equally distributed.
| Ablation procedure
The PVI was performed guided by two 7-F decapolar circular catheters (Lasso, Biosense-Webster, Inc.) positioned at the ipsilateral PV ostia. At the anterior aspect of the left PVs, an ablation line was created along the ridge between the LAA and PV ostium. Each radiofrequency (RF) energy application was delivered for 40s. A 3.5 mm irrigated tip RF catheter (Safire, St. Jude Medical Inc.) was used with the temperature limited to 42°C and power to 30W (with a flow rate of 13 mL/min). A maximum power of ≤25W was used while delivering energy to sites near the esophagus. After the elimination or dissociation of the PV potentials, exit block was confirmed by pacing from circular catheters placed within the PVs.
After the PVI, frequency analyses were performed. And LA voltage map was constructed during sinus rhythm (SR) after external cardioversion. The procedure was completed with a cavotricuspid isthmus ablation in all patients who regained sinus rhythm.
| Frequencies analysis
DF mapping was performed during AF after PVI. The fast Fourier transform (FFT) method has been described previously. 5, 6, 15 Recordings at each site were 5 seconds in length using a high-density (HD) 16 LVA was defined as area with bipolar peakto-peak electrogram amplitude <0.5 mV and electrical scar areas were continued for at least 3 months to prevent any early recurrences. AF recurrence was defined as sustained AF lasting more than 30 seonds, which occurred more than 3 months after the catheter ablation. 14 
| Statistical analysis
The continuous variables are presented as the mean AE standard deviation together with 95% confidence intervals. Categorical variables are expressed as numbers and percentages. The significance of any differences between two groups was analyzed with an unpaired t test and Mann-Whitney U test for continuous variables, and with a
Fisher's exact probability test for categorical variables. A predictive analysis of AF recurrence during the follow-up period was assessed using multivariate Cox proportional hazard regression models. A multivariate analysis with multivariate Cox proportional hazard regression models was performed to isolate the independent criteria of AF recurrence after ablation. Only the variables with significant P-values in the univariate analysis were included in the multivariate Cox proportional hazard regression. A Kaplan-Meier event-free survival analysis was conducted to assess the cumulative freedom from AF recurrence. A value of P < .05 was considered statistically significant.
3 | RESULTS
| Patient characteristics
The patient characteristics are shown in 
| Outcome of the catheter ablation
A PVI was successfully achieved in all PVs. AF freedom off AADs was 68.3% and 69.0%, respectively, in the persistent and long-standing AF patients after 1 procedure over a 12-month follow-up period.
The patients were divided into two groups, those in whom AF was prevented by catheter ablation (AF-free group, n = 48) and those in whom AF recurred (AF-recurrent group, n = 22). The patient characteristics and laboratory data did not differ between the two groups except for the LA diameter in the AF-recurrent group as compared to the AF-free group (Table 1) . The SR ratio at the start of the procedure and AF termination during ablation did not differ between the two groups ( Table 2) . In 2 patients, the PVI was performed under SR after cardioversion due to unstable hemodynamic conditions. The RF time for the PVI and total procedure time did not differ between the two groups. There were no cases of cerebral infarctions, cardiac perforations, tamponades, PV stenosis, or atrialesophageal fistulae.
| LVAs and frequencies analysis
The characteristics of the LVAs and frequencies are shown in Table 3 shows the overlap between the LVAs and high-DF sites.
High-DF sites were found in 39 (85%) of 46 patients in whom DF mapping was performed during AF after the PVI. The number of the high-DF sites in the LA and RA was 1.7 and 0.6 per patient after the PVI, respectively. The max-DF value was found at the LVAs in 31 (79.5%) of 39 patients with high-DF sites. The max-DF value in the LA and RA did not differ between the AF-free and AF-recurrent groups ( Table 2 ). were frequently identified at the inferior wall, anterior wall, and roof of the LA. There were no significant differences in the number of high-DF sites that overlapped with or were at border zones of LVAs in any LA segments between the two groups ( in persistent AF patients, the LA max-DF value, not LVAs, exhibited a significant difference between the two groups.
| Previous reports of LVAs
LVAs were defined as areas with bipolar peak-to-peak voltage amplitudes of <0.5 mV. The definition of the value was based on the minimum grade of LA fibrosis evaluated by delayed-enhancement magnetic resonance imaging (MRI). 9 An increased amount of fibrosis as detected by LA voltage mapping has been shown to be a predictor of atrial tachycardia and AF recurrence after AF ablation. [9] [10] [11] [12] [13] LVAs have the electrophysiological effects of altered conduction, heterogeneous refractoriness, and rapid repetitive activity. 18, 19 In addition, LVAs have a regional distribution of the septum, anterior, inferior, and posterior wall of the LA as we described in this study, which may be related to contact from external structures, including the aorta and vertebrae. 20 
| Optimal size of LVAs for substrate modification
The relationship between the size of the LVAs and AF recurrence has not been fully evaluated. In the previous report using delayedenhancement MRI, according to the extent of enhancement, atrial remodeling of the LA wall was divided into 3 types; mild enhancement of <15%, moderate enhancement between 15% and 35%, and extensive enhancement of >35%. 9 However, the optimal LVA size required for an additional substrate modification remains unclear. In this study, a cut-off of 24% for the LVA was determined for the freedom from AF recurrence after the PVI. AF freedom had a good result of 78.6% in those with LVAs of ≤24% after a PVI alone. In addition, AF freedom in patients with no LVAs had a good result (92%), indicating that substrate modification is unnecessary in nonparoxysmal patients without LVAs. The LVAs at the anterior, lateral, and posterior wall of the LA could be found more frequently in the AF-recurrent group. Although various additional LVA-based substrate modifications after the PVI have been reported in nonparoxysmal AF patients with LVAs, the outcome and approaches vary widely due to the size and distribution of the LVAs. [11] [12] [13] In many AF patients, individually located sites and/or patchy fibrotic areas that may be specifically targeted for ablation have been found. However, some AF patients present with diffuse, massive fibrosis without an apparent curative ablation approach. Intrinsically, all LVAs may not always be ablated for the modification. This study also indicated that the LVAs after the PVI were not an independent predictor for AF recurrence as described previously. 21 Excessive lesion sets for substrate modification may lead to totally new atrial arrhythmias. 22 Therefore, an optimal LVA size may be helpful for deciding the need for additional substrate modification in nonparoxysmal AF patients after PVI.
| Relationship between LVAs and High-DF sites
Atrial sites that represent local electrograms with high-DFs may be associated with AF maintenance. 5, 6, 15 In a previous report, high-DF sites were mainly observed on the septum and bottom of the LA.
High-DF sites after PVI were observed at an average of 6.0 AE 3.3 sites (3.8 AE 2.3 in the LA and 2.3 AE 1.8 in the RA) per patient in nonparoxysmal AF. 23 However, the relationship between LVAs and high-DF sites has not been evaluated yet. In the present study, 72%
of high-DF sites overlapped with LVAs. In addition, about half of the high-DF sites overlapped with LVAs at border zones of LVAs.
Therefore, the high-DF sites were closely related to LVAs in nonparoxysmal AF. LVAs are known to be associated with the electrophysiological effects of an altered conduction velocity, heterogeneous refractoriness, and rapid repetitive activity. [18] [19] [20] Ablation of sites harboring distinct regional electrogram characteristics within/in the vicinity of low-voltage areas in addition to PVI is more effective than conventional PVI only strategy for persistent AF. 24 Therefore, fractionated activity, rotational activity, or discrete rapid local activity during AF may contribute to the formation of high-DFs. 24 Although the high-DF area changed spatiotemporally, virtual ablation for high-DF areas remained effective in the defragmentation of AF, including AF termination or changing into AT in silico human AF models. A high-DF site ablation may modify the atrial substrate necessary to maintain AF in LVAs. However, in this study, there were no significant differences in the max-DF value and number of high-DF sites overlapping with LVAs in the LA between the two groups. That may be because the relationship between LVAs and sites without highDFs was not evaluated. In patients with advanced atrial remodeling, the max-and mean DF values in AF were lower and the number of high-DF sites remained small. 5 
| LVAs in persistent AF
In persistent AF patients, the LA max-DF value, not the LVA/LA surface area, had significant differences between the AF-free and AF-recurrent groups, which differed from the findings including long-standing persistent AF. This may support that a high-DF site ablation following PVI is effective in persistent AF patients as described in a previous report. 5 Therefore, in patients with a lesser amount of LVAs, high-DF sites may be a potential target for sustaining AF.
| Study limitations
The present study was limited in several ways. First, the number of patients included in the present study was too small to draw definite conclusions. Second, we did not evaluate the relationship between
LVAs and the max-DF value of <8 Hz sites. In many patients with a severe AF burden, high-DF sites often could not be found. Therefore, the effect of LVAs overlapping with DF sites of <8 Hz for AF recurrence is unclear. Third, AF recurrence was evaluated using sur- and high-DF sites was not ablated after the PVI in the present study.
Accordingly, it is unclear whether RF applications at the overlap between the LVAs and high-DF sites were actually effective for AF freedom. This strategy may avoid atrial arrhythmias caused by excessive RF applications as compared with an additional LVA-based substrate modification as described previously. To draw definite conclusions, further prospective study is needed with additional RF applications performed at overlaps between LVAs and high-DF sites as compared to PVI alone.
| CONCLUSIONS
LVAs were associated with AF recurrences after PVI in nonparoxysmal AF patients and overlapped with many high-DF sites. PVI alone may be enough to treat patients with mild-to-moderate extent (≤24%) of LVAs.
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